IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Mucopolysaccharidosis (MPS)
Takedamonoclonal_antibodyPhase 4 / ApprovedActive
BB
68/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 53/ 100
- Competitive Position
- 95/ 100
Competitive context
5 Active assets in the Mucopolysaccharidosis (MPS) cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
.BETA.-GLUCURONIDASE (SYNTHETIC HUMAN), HOMOTETRAMER Ultragenyx Pharmaceutical Inc | Phase 3 | BBB |
gc1111 Takeda | Phase 4 | BB |
METHOTREXATE Takeda | Phase 4 | BB |
HUMAN IMMUNOGLOBULINS Takeda | Phase 4 | B |
Busulphan Masonic Cancer Center, University of Minnesota | Phase 2 | B |
View all 13 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →